Completed NCT02712463
This study is completed in Brazil and in Mexico. It is testing rate of Hospitalization for schizophrenia.
Multiple locations, including Aracaju Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. From 18 Years to 55 Years
Countries Brazil, Mexico
Sponsor Janssen-Cilag Ltd.
Condition Schizophrenia Completed NCT00210717
This study is completed. It focuses on schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. Over 18 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT00645372
This study is completed in China. It is testing ziprasidone and Risperidone for schizophrenia.
Multiple locations, including Beijing Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries China
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia Completed NCT01654601
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Choongju Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 20 Years to 60 Years
Countries South Korea
Sponsor Dong Wha Pharmaceutical Co. Ltd.
Condition Schizophrenia Completed NCT00392743
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Barcelona Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational Over 18 Years
Countries Spain
Sponsor GlaxoSmithKline
Condition Schizophrenia Completed NCT03627195
This study is completed in the United States. It focuses on schizophrenia.
In Long Beach Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Sumitomo Pharma America, Inc.
Condition Schizophrenia Completed NCT02624167
This study is completed in the United States and in India. It focuses on schizophrenia.
Multiple locations, including Garden Grove Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, India
Sponsor Newron Pharmaceuticals SPA
Condition Schizophrenia Completed NCT01655680
This study is completed in the United States, in the United Kingdom, and in Russia. It is testing ABT-126 for schizophrenia.
Multiple locations, including Anaheim Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 20 Years to 65 Years
Countries United States, United Kingdom, Russia
Sponsor AbbVie (prior sponsor, Abbott)
Condition Schizophrenia Completed NCT00396565
This study is completed in Japan. It is testing Effectiveness and Safety of ER OROS Paliperidone for schizophrenia.
Multiple locations, including Aizu-Wakamatsu Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 20 Years
Countries Japan
Sponsor Janssen Pharmaceutical K.K.
Condition Schizophrenia Completed NCT01192880
This study is completed in the United States, in Bulgaria, in China, .... It is testing bitopertin for schizophrenia.
Multiple locations, including Costa Mesa Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States, Bulgaria, China, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT01577160
This study is completed. It is testing Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Johnson & Johnson Taiwan Ltd
Condition Schizophrenia Completed NCT01010776
This study is completed in Brazil. It is testing Flexible-Dose of Paliperidone Extended Release (ER) for schizophrenia.
Multiple locations, including Belo Horizonte Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries Brazil
Sponsor Janssen-Cilag Farmaceutica Ltda.
Condition Schizophrenia